Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Yana Astter
Observed name:
David A. Davis
Institutions:
National Institutes of Health,
National Cancer Institute,
National Cancer Institute,
National Cancer Institute,
Center for Cancer Research
Observed institutions:
National Institutes of Health,
National Cancer Institute,
National Cancer Institute,
National Cancer Institute,
Center for Cancer Research
ORCID:
0000-0002-9527-7007
Observed ORCIDs:
0000-0002-9527-7007,
0000-0001-6277-9687
OpenAlex ID:
A5031342643
Daratumumab induces cell-mediated cytotoxicity of primary effusion lymphoma and is active against refractory disease
2023
·
Prabha Shrestha
, Yana Astter
, et al.
·
OncoImmunology
·
13
PDF
Discovery of a nasal spray steroid, tixocortol, as an inhibitor of SARS-CoV-2 main protease and viral replication
2024
·
David A. Davis
, Ashwin Nair
, et al.
·
RSC Medicinal Chemistry
·
7
PDF
Caspase cleavage of Kaposi sarcoma-associated herpesvirus proteins: a role for K5 in preventing caspase-mediated cell death during lytic replication
2025
·
Yana Astter
, David A. Davis
, et al.
·
Journal of Virology
·
2
Author response for "Discovery of a Nasal Spray Steroid, Tixocortol, as an Inhibitor of SARS-CoV-2 Main Protease and Viral Replication"
2024
·
David A Davis
, Ashwin Nair
, et al.
·
Publons reviews and discussion
Hardness of deposited silica nanoparticle thin films
2020
·
Yana Astter
, Grace Baker
, et al.
Hardness of deposited silica nanoparticle thin films
2020
·
Yana Astter
, Grace Baker
, et al.
Show more works
View as search
Works count:
6
Citation count:
22
H-index:
2
I10-index:
1
Year
Topic
Type